Solution: replacing coal with new nuclear power.

financial return (NPV).a portfolio of new pharmaceutical products.

I started with the basis that each new product would follow one of four trajectories of sales.The first would be that it hit a base demand., the second 1.5 x base demand, the third 0.5 x base demand and the fourth did not get launched or sold at all or 0.

The demand curves were normalised curves.. To simply represent a portfolio of products I allocated a probability to each of the four trajectories.. Then I looked at scale.I used a few API (chemical synthesis) projects to normalise a base scale.

I then looked at relative scales around this.

The smallest being.Generative design can create unexpected options with high value.. We are now working on making Chips available to very large numbers of users through a web interface, to use generative design for pharmaceutical plants.

We are also associating process simulation data with those Chips, so that we can look at throughput, and use throughput to define what Chips we need..The Chip as future enabler.

We are often asked what ‘Chip’ stands for.It doesn't stand for anything.